MergerLinks Header Logo

Announced

Completed

GL Capital led a $290m round in Sangon Biotech.

Synopsis

GL Capital, an investment firm, led a $290m round in Sangon Biotech, a biotechnology company, with participation from CITIC Private Equity, Greenwoods Investment and Huagai Capital. Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

Principals

Sangon Biotech

target

Sangon Biotech

Gl Capital Group

bidder

Gl Capital Group

Show Details & Financials

Market Context

Sort

Jeffrey Li

Jeffrey Li

InvestorFounder and CEO at GL CAPITAL GROUP
Deal Bio
Total Deals
3/
Total Value
£420M
Yichen Zhang

Yichen Zhang

InvestorCEO at CITIC PRIVATE EQUITY FUNDS MANAGEMENT
Deal Bio
Total Deals
26/
Total Value
£23,125M
George Jiang

George Jiang

InvestorCEO at GREENWOODS INVESTMENT
Deal Bio
Total Deals
2/
Total Value
£349M
Lu Binghui

Lu Binghui

InvestorPresident & Co-Founder at HUAGAI CAPITAL
Deal Bio
Total Deals
1/
Total Value
£233M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US